[Translation] A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of Romosozumab in Chinese postmenopausal women with osteoporosis
主要目的:与安慰剂比较评价Romosozumab治疗6个月对中国绝经后骨质疏松症女性腰椎BMD %变化的影响 双盲对照期的次要目的:与安慰剂比较评价Romosozumab治疗6个月对中国绝经后骨质疏松症女性全髋和股骨颈BMD %变化的影响 双盲对照期的安全性目的:与安慰剂比较总结Romosozumab治疗中国绝经后骨质疏松症女性的安全性和耐受性
[Translation] Primary objective: To evaluate the effect of 6-month treatment with Romosozumab on the % change of lumbar spine BMD in Chinese postmenopausal women with osteoporosis compared with placebo Secondary objective of the double-blind controlled period: To evaluate the effect of 6-month treatment with Romosozumab on the % change of total hip and femoral neck BMD in Chinese postmenopausal women with osteoporosis compared with placebo Safety objective of the double-blind controlled period: To summarize the safety and tolerability of Romosozumab in the treatment of Chinese postmenopausal women with osteoporosis compared with placebo